bcbs michigan glp-1 2025 coverage change for drugs to treat obesity Michigan cuts off weight-loss drugs
Description
Is the GLP-1 drug shortage resolution likely improving persistence
Does using GLP-1 for binge eating actually work
Our new whitepaper combines data from the QYOBO Platform - prices, API manufacturers, compliance signals - with commentary from Thomas Tong, CEO of Sinopep-Allsino Biopharmaceutical Co., Ltd., the leading API manufacturer in this space
Closing the "Vitamin Add-On" Loophole For a long time, some pharmacies argued that adding Vitamin B12 or other ingredients created a "new" medication that wasn't a copy of the brand name
The situation is causing the FDA regulatory headaches and, more seriously, posing potential risks to the public.
